Health Minister has published Northern
Ireland's new Cancer Research Strategic Framework designed to
strengthen cancer research, innovation and collaboration across
Northern Ireland.
The Framework sets out a clear direction for enhancing research
excellence, removing barriers, increasing participation in
clinical trials, and improving outcomes for cancer patients. It
builds on the ambitions of the NI Cancer Strategy and aligns with
the Health and Care Reset Plan commitment to develop a
world-leading health and care research and innovation ecosystem.
A new Cancer Research Advisory Group will oversee delivery of the
Framework. The Group will be co-chaired by Professor Ian Young,
Chief Scientific Adviser at the Department of Health, and
Professor Mark Lawler, Professor of Digital Health and Chair in
Translational Cancer Genomics at Queen's University Belfast, with
Cancer Research UK as a key member.
Health Minister said: “This
Framework demonstrates a clear commitment to strengthening cancer
research in Northern Ireland. By uniting expertise across health
and social care, academia, industry and the voluntary sector, we
can accelerate progress and deliver real improvements in
prevention, diagnosis and treatment.
“Our researchers and clinicians already make an
outstanding contribution to cancer care. This Framework ensures
they are supported to continue that work, driving innovation that
will translate directly into better outcomes for patients. I am
very grateful to everyone who has contributed to its
development.”
Professor Ian Young said: “The Cancer Research Advisory
Group will play a pivotal role in ensuring that the Framework
delivers on its ambitions. By building capacity, fostering
collaboration and strengthening infrastructure, we can create the
conditions needed for high-quality research that benefits
patients.”
Professor Mark Lawler said: “I praise the Minister for this
initiative – it's the first time we've had a Cancer Research
Strategic Framework. Make no mistake, this is a pivotal
moment for cancer research in Northern Ireland. Cancer research
is no longer a “nice to have”. It's a “must have” in order to
deliver 21st century care for our patients. By connecting our
scientific, clinical, innovation and patient communities, we can
enhance our research efforts, attract investment, and ensure
discoveries are rapidly translated into better care and outcomes.
I am honoured to serve as Co-Chair to what I believe is a new
dawn for cancer research in Northern Ireland.”
The launch of the Framework and Advisory Group reinforces
Northern Ireland's growing reputation for excellence in health
research and innovation. It underlines the Department's
determination to ensure that world-class science and
collaboration continue to improve the lives of people affected by
cancer.
Notes to editors:
- Link to framework document New Cancer Research Strategic
Framework for Northern Ireland